Biochemical Pharmacology, Journal Year: 2024, Volume and Issue: unknown, P. 116699 - 116699
Published: Dec. 1, 2024
Language: Английский
Biochemical Pharmacology, Journal Year: 2024, Volume and Issue: unknown, P. 116699 - 116699
Published: Dec. 1, 2024
Language: Английский
Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 257, P. 155315 - 155315
Published: April 17, 2024
Language: Английский
Citations
1Biomedicine & Pharmacotherapy, Journal Year: 2024, Volume and Issue: 180, P. 117480 - 117480
Published: Oct. 1, 2024
Language: Английский
Citations
1Biochemical Pharmacology, Journal Year: 2024, Volume and Issue: 232, P. 116691 - 116691
Published: Dec. 3, 2024
Language: Английский
Citations
1International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(17), P. 13480 - 13480
Published: Aug. 30, 2023
Alzheimer’s disease (AD) is the most common form of dementia that affects millions individuals worldwide. Although research over last decades has provided new insight into AD pathophysiology, there currently no cure for disease. often only diagnosed once symptoms have become prominent, particularly in late-onset (sporadic) AD. Consequently, it essential to further avenues early diagnosis. With recent advances genomic analysis and a lower cost use, exploration genetic markers alongside RNA molecules can offer key avenue We here brief overview potential differentially expressed peripheral tissues cases compared controls, as well considering changes dynamics molecules. By integrating both genotype reported AD, biomarker profiling be developing reliable diagnostic tools.
Language: Английский
Citations
2Biochemical Pharmacology, Journal Year: 2024, Volume and Issue: unknown, P. 116699 - 116699
Published: Dec. 1, 2024
Language: Английский
Citations
0